20 May 2013
Keywords: eu, patients, unequal, access, new, drugs, average
Article | 10 June 2002
On average, UK patients gain access to new medicines six months afterEuropean Union marketing authorization, while in Portugal and France
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 June 2002
17 May 2013
© 2013 thepharmaletter.com